|
Summary
March 2008, Vol. 17, No. 3, Pages 269-283
, DOI 10.1517/13543784.17.3.269
Discontinued drugs in 2006: oncology drugsRobert WilliamsHead of Projects & Non-clinical Development, Drug Development Office, Cancer Research UK, 61 Lincoln's Inn Fields, London WC2A 3PX, UK +44 (0)20 7121 6900; Robert.williams@cancer.org.uk This perspective is the last in a series of papers discussing drugs dropped from clinical development in 2006. Specifically, this paper focuses on the 16 drugs discontinued for the treatment of cancer, the largest area of pharma R&D. This was based on a search of the Pharmaprojects database for drugs reaching Phase I – III clinical trials. Forward Links to Citing ArticlesRobert Williams. (2008) Discontinued drugs in 2007: oncology drugs. Expert Opinion on Investigational Drugs 17:12, 1791-1816 Online publication date: 1-Dec-2008. Summary | Full Text | PDF (348 KB) | PDF Plus (308 KB) Users who read this article also read:
|
|
TOC Alert